Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
No part of this website may be copied, reproduced, modified, published, displayed, or used for commercial or other purposes without my prior written consent
That opportunity is now supported by manufacturing commitments, including Novo Nordisk's March 2026 announcement of a EUR 432 million expansion in Athlone, Ireland, to increase capacity for oral GLP-1 therapies, alongside Eli Lilly's November 2025 plan to build a USD 3 billion manufacturing facility in Katwijk, the Netherlands, aimed at oral medicines including the GLP-1 receptor agonist orforglipron
Studies have shown that once-weekly GLP-1 formulations reduce the risk of non-adherence by 11% compared to daily injections
What happens if I need to stop due to cost
PMID: 8429294
US$ 25.44
US$ 22.62
US$ 26.83
US$ 24.72
US$ 28.29
